コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 njury and potential treatment strategies for maple syrup urine disease.
2 tress shown to cause encephalopathy in human maple syrup urine disease.
3 chain amino acid metabolism resembling human maple syrup urine disease.
4 patocytes from patients and a mouse model of maple syrup urine disease.
5 henylketonuria, branched chain ketoaciduria (maple syrup urine disease) and homocystinuria, which are
7 cine, isoleucine, and valine are elevated in maple syrup urine disease, heart failure, obesity, and t
8 metabolic correction of a mouse intermediate maple syrup urine disease (iMSUD) model after allogenic
9 two converging mechanisms of brain injury in maple syrup urine disease including: (i) neurotransmitte
11 ially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein
12 toacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment
20 that natural mutations of these residues in maple syrup urine disease (MSUD) patients (R114W-alpha a
23 intermittent or intermediate types of human maple syrup urine disease (MSUD), a hereditary disorder
24 and cause multiple human diseases including maple syrup urine disease (MSUD), autism, and other rela
25 determined RBC UDPgalactose in patients with maple syrup urine disease (MSUD), phenylketonuria (PKU),
29 orleucine to heterozygous mothers of classic maple syrup urine disease pups reduced branched-chain am
32 ped mouse models of classic and intermediate maple syrup urine disease, we assessed biochemical, beha
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。